Resource Center
At Eurofins Viracor, our Fighting Fungals brochure highlights our robust fungal testing menu, differential testing capabilities, and commitment to delivering faster results to aid in anti-fungal therapy monitoring. We understand the critical nature of invasive fungal diseases (IFDs), particularly among immunocompromised patients such as organ transplant recipients, HIV/AIDS patients, and those battling cancer. Our advanced diagnostics enable early detection and precise treatment strategies, empowering healthcare providers to optimize patient care and improve outcomes in managing these potentially life-threatening infections.
This bi-lateral lung transplant recipient is a 65 year-old male patient who received his lung transplant due to end-stage lung disease secondary to non-CF bronchiectasis. The donor and recipient CMV serostatus is D+/R+. The patient’s initial peri-operative course was complicated by difficult explant, primary graft dysfunction, respiratory failure requiring prolonged mechanical ventilation, renal insufficiency and recurrent infectious concerns, including pseudomonas and stenotrophomonas pneumonias.